CSTONE PHARMA-B

02616

----

Current ValuationThe current P/E ratio is -16.67, within the reasonable range, cheaper than 41.25% of the time in the past 3 years, and the industry ranks 58/78, the industry Median -5.11.

-16.67xP/E

Stock priceHK$5.04Earnings per shareHK$-0.30

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

0163326489652

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
09926HKAKESO	-78.43x	75.71%	HK$87.34B
09688HKZAI LAB	-15.25x	378.87%	HK$22.51B
01877HKJUNSHI BIO	-38.16x	85.34%	HK$17.66B
09606HKDUALITYBIO-B	-9.37x	85.62%	HK$15.51B
07666HKMETIS TECHBIO-P	-33.41x	96.71%	HK$13.60B
01952HKEVEREST MED	-205.90x	324.72%	HK$12.78B
02595HKGENFLEET-B	-7.78x	66.07%	HK$11.79B
06855HKASCENTAGE	-6.93x	18.76%	HK$11.72B
02627HKAB&B BIO-TECH-B	-46.87x	--	HK$11.54B
06938HKRIBOLIFE-B	-45.71x	29.56%	HK$8.93B
02493HKMABWELL-B	-7.94x	--	HK$8.60B
02616HKCSTONE PHARMA-B	-16.67x	1.77%	HK$8.05B
09887HKLEADS BIOLABS-B	-25.83x	3.57%	HK$7.94B
02171HKCARSGEN-B	-69.45x	51.05%	HK$7.13B
09966HKALPHAMAB-B	-34.67x	--	HK$7.02B
01672HKASCLETIS-B	-9.20x	78.53%	HK$6.27B
02335HKMICOT PHARMA-B	-12.90x	37.52%	HK$5.41B
02256HKABBISKO-B	-10.05x	301.05%	HK$5.40B
01779HKLONGBIO-B	-21.20x	--	HK$5.28B
06872HKTENNOR THERAP-B	-32.85x	--	HK$5.27B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.